Literature DB >> 14872340

Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation.

Masanori Adachi1, Masato Shinkai, Youkatsu Ohhama, Katsuhiko Tachibana, Tadatoshi Kuratsuji, Hiroh Saji, Etsuko Maruya.   

Abstract

UNLABELLED: Patients with glycogen storage disease type 1b (GSD1b) not only show hepatomegaly, hypoglycaemia and lactic acidosis, but also neutropenia and neutrophil dysfunction. Here, we report improvement of neutropenia and neutrophil function in a 22-year-old male GSD1b patient who had undergone living-related partial liver transplantation (LT) at 18 years of age. After LT, the patient's infectious episodes decreased, gastrointestinal symptoms ameliorated, neutrophil counts increased, and neutrophil function tests normalised.
CONCLUSION: Although it is not known whether this improvement was causally related to liver transplantation, this may be the first recorded case of restoration of neutrophil dysfunction in a glycogen storage disease type 1b patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872340     DOI: 10.1007/s00431-004-1405-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Glycogen storage disease type Ib without neutropenia.

Authors:  S Kure; D C Hou; Y Suzuki; A Yamagishi; M Hiratsuka; T Fukuda; H Sugie; N Kondo; Y Matsubara; K Narisawa
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors.

Authors:  T F Roe; T D Coates; D W Thomas; J H Miller; V Gilsanz
Journal:  N Engl J Med       Date:  1992-06-18       Impact factor: 91.245

3.  Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia.

Authors:  A López-Sanromán; P Martín-Vaquero; E Molina-Pérez; R Bárcena; E Vicente; L F Pallardo-Sánchez
Journal:  Clin Nutr       Date:  2001-08       Impact factor: 7.324

4.  Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O2-.

Authors:  M Nakano; K Sugioka; Y Ushijima; T Goto
Journal:  Anal Biochem       Date:  1986-12       Impact factor: 3.365

5.  Amount of co-transplanted donor-derived leukocytes determines in-vivo microchimerism and mixed lymphocyte culture changes post-liver transplantation.

Authors:  S Weber; R Salguero; C Allers; R A Blaheta; B H Markus
Journal:  Zentralbl Chir       Date:  2003-04       Impact factor: 0.942

6.  Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.

Authors:  Rosanna Leuzzi; Gábor Bánhegyi; Tamás Kardon; Paola Marcolongo; Piero-Leopoldo Capecchi; Hans-Joerg Burger; Angelo Benedetti; Rosella Fulceri
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

7.  Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype.

Authors:  B W Weston; J L Lin; J Muenzer; H S Cameron; R R Arnold; H H Seydewitz; E Mayatepek; E Van Schaftingen; M Veiga-da-Cunha; D Matern; Y T Chen
Journal:  Pediatr Res       Date:  2000-09       Impact factor: 3.756

8.  Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.

Authors:  A Lachaux; O Boillot; D Stamm; I Canterino; C Dumontet; F Regnier; D Floret; M Hermier
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

9.  Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.

Authors:  T E Starzl; A J Demetris; M Trucco; C Ricordi; S Ildstad; P I Terasaki; N Murase; R S Kendall; M Kocova; W A Rudert
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

10.  Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus.

Authors:  K J Lei; Y T Chen; H Chen; L J Wong; J L Liu; A McConkie-Rosell; J L Van Hove; H C Ou; N J Yeh; L Y Pan
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

View more
  9 in total

1.  Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients.

Authors:  Gepke Visser; Wilco de Jager; Liesbeth P Verhagen; G Peter A Smit; Frits A Wijburg; Berent J Prakken; Paul J Coffer; Miranda Buitenhuis
Journal:  J Inherit Metab Dis       Date:  2011-08-24       Impact factor: 4.982

Review 2.  Gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

3.  Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Authors:  W H Yiu; C-J Pan; M Allamarvdasht; S Y Kim; J Y Chou
Journal:  Gene Ther       Date:  2006-09-28       Impact factor: 5.250

Review 4.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

Review 5.  The SLC37 family of phosphate-linked sugar phosphate antiporters.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 6.  Neutropenia in type Ib glycogen storage disease.

Authors:  Janice Y Chou; Hyun S Jun; Brian C Mansfield
Journal:  Curr Opin Hematol       Date:  2010-01       Impact factor: 3.284

Review 7.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

Review 8.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

9.  Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b.

Authors:  Kyung Jae Lee; Shin Jie Choi; Woo Sun Kim; Sung-Sup Park; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-03-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.